HEALTHCARE & MEDICARE
1 hour ago
Verily joins forces with Samsung to bring smartwatch data into clinical trials
Verily and Samsung are working together to integrate data from Galaxy smartwatches into Verily's Pre…
HEALTHCARE & MEDICARE
7 hours ago
Alfasigma pays $300 million for rights to GSK's rare liver disease drug, awaits FDA decision
GSK has granted Alfasigma global rights to Linerixibat, a treatment for the rare liver disease…
FRAUD PREVENTION
11 hours ago
Mastercard says artificial intelligence and artificial intelligence will be the future of fraud prevention
Mastercard says artificial intelligence (AI) is fueling “unprecedented” levels of fraud and cybercrime. It may…
HEALTHCARE & MEDICARE
11 hours ago
HIPAA was built for the analog age, and healthcare AI has moved beyond it
Healthcare AI in the United States has advanced to the point where traditional HIPAA-style compliance…
HEALTHCARE & MEDICARE
12 hours ago
Dialysis is not optional. Neither can transportation.
NEMT enables dialysis for thousands of patients every day. Should we stop viewing medical transportation…
HEALTHCARE & MEDICARE
23 hours ago
It took Congress several years to enact PBM transparency and decoupling. What about vertical integration?
Despite recent pharmacy benefit management reforms, the chances of passage of the bipartisan Break Up…
HEALTHCARE & MEDICARE
1 day ago
Why this rural health system is expanding artificial intelligence for point-of-care decisions
Presbyterian Healthcare Services has rolled out its AI-powered precision care platform to 200 primary care…
Social Security
1 day ago
North Carolina Personal Injury: Top 10 Barriers to Recovery
Unfortunately, simply being injured by another person is not enough to file a North Carolina…
FRAUD PREVENTION
1 day ago
Trump wants Justice Department to prioritize cybercrime cases
President Donald Trump Hope his administration will crack down on “predatory” schemes targeting American consumers…
HEALTHCARE & MEDICARE
1 day ago
Roche, Zealand Pharma obesity drug meets clinical trial weight loss target, but can it compete?
Petrelintide released phase 2 results showing it was tolerable as well as placebo, but average…
























